moclobemide has been researched along with Briquet Syndrome in 2 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pirildar, S | 1 |
| Sezgin, U | 1 |
| Elbi, H | 1 |
| Uyar, M | 1 |
| Zileli, B | 1 |
| Rütten, J | 1 |
1 trial available for moclobemide and Briquet Syndrome
| Article | Year |
|---|---|
A preliminary open-label study of moclobemide treatment of pain disorder.
Topics: Adult; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Moclobemide; Mon | 2003 |
1 other study available for moclobemide and Briquet Syndrome
| Article | Year |
|---|---|
[Moclobemide in treatment of somatoform depression. A case report].
Topics: Activities of Daily Living; Aged; Benzamides; Depressive Disorder; Female; Humans; Moclobemide; Mono | 1994 |